In our latest research - conducted on behalf of Roche - Ipsos MORI focus in on trust in scientific information from different sources, and how the major pharmaceutical companies compare with the NHS. Does something being widely shared make it more trusted, or less?
The research highlights the high level of trust the public places in the NHS (71% more trust it than distrust it) compared to pharmaceutical companies (net 9%). Despite rising trust in science and scientists over the last decade, who they are employed by has a major impact on how credible they are likely to be regarded. However as our work on trust in business and other organisations in our Ipsos Global Trends survey shows, overall pharmaceutical companies outperform most national governments and most utility companies in terms of being seen as fair and honest, standing mid table.
Drug pricing controversies are here to stay – what do consumers think?
Drug pricing has long been a key reputational issue for the pharmaceutical industry in the eyes of consumers. In light of recent media coverage of this issue, it is unlikely that perceptions are going to shift any time soon. However, many senior stakeholder groups are positive about the future of Pharmaceuticals.